241 related articles for article (PubMed ID: 37237497)
1. Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses.
Láinez-González D; Alonso-Aguado AB; Alonso-Dominguez JM
Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237497
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Notch Signaling Pathway in Acute Myeloid Leukemia Stem Cells: From Hematopoiesis to Neoplasia.
Láinez-González D; Serrano-López J; Alonso-Dominguez JM
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326610
[TBL] [Abstract][Full Text] [Related]
3. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
[TBL] [Abstract][Full Text] [Related]
4. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia].
Sakoda T; Kikushige Y
Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480
[TBL] [Abstract][Full Text] [Related]
5. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
[TBL] [Abstract][Full Text] [Related]
6. TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia.
Sakoda T; Kikushige Y; Miyamoto T; Irifune H; Harada T; Hatakeyama K; Kunisaki Y; Kato K; Akashi K
Blood Adv; 2023 May; 7(10):2053-2065. PubMed ID: 36745103
[TBL] [Abstract][Full Text] [Related]
7. Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence.
O'Reilly E; Zeinabad HA; Nolan C; Sefy J; Williams T; Tarunina M; Hernandez D; Choo Y; Szegezdi E
Front Cell Dev Biol; 2021; 9():662868. PubMed ID: 34589478
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
[TBL] [Abstract][Full Text] [Related]
9. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
11. IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways.
Naef P; Radpour R; Jaeger-Ruckstuhl CA; Bodmer N; Baerlocher GM; Doehner H; Doehner K; Riether C; Ochsenbein AF
Sci Signal; 2023 Aug; 16(800):eadd7705. PubMed ID: 37643244
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure.
Lainez-González D; Serrano-López J; Alonso-Domínguez JM
Biology (Basel); 2021 Mar; 10(4):. PubMed ID: 33804919
[TBL] [Abstract][Full Text] [Related]
13. Cell signaling pathways as molecular targets to eliminate AML stem cells.
Rodrigues ACBDC; Costa RGA; Silva SLR; Dias IRSB; Dias RB; Bezerra DP
Crit Rev Oncol Hematol; 2021 Apr; 160():103277. PubMed ID: 33716201
[TBL] [Abstract][Full Text] [Related]
14. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia.
Chiarini F; Paganelli F; Martelli AM; Evangelisti C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046053
[TBL] [Abstract][Full Text] [Related]
15. Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy.
Kikushige Y
Blood Cell Ther; 2022 Dec; 5(Spec Edition):S1-S5. PubMed ID: 37220607
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia: therapeutic targeting of stem cells.
Pabon CM; Abbas HA; Konopleva M
Expert Opin Ther Targets; 2022 Jun; 26(6):547-556. PubMed ID: 35634856
[TBL] [Abstract][Full Text] [Related]
17. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
Chen Y; Li J; Xu L; Găman MA; Zou Z
Cell Death Discov; 2022 Sep; 8(1):397. PubMed ID: 36163119
[TBL] [Abstract][Full Text] [Related]
18. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
[TBL] [Abstract][Full Text] [Related]
19. TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways.
Kikushige Y
Cancer Sci; 2021 Sep; 112(9):3419-3426. PubMed ID: 34159709
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.
Hansen Q; Bachas C; Smit L; Cloos J
Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
